Jeffrey Barocas - 09 Aug 2022 Form 4 Insider Report for OCEAN BIO CHEM INC

Role: Chief Financial Officer, Director
Signature: /s/ Jeffrey Barocas
Issuer symbol: N/A
Transactions as of: 09 Aug 2022
Net transactions value: -$2,345,649
Form type: 4
Filing time: 09 Aug 2022, 14:16:08 UTC
Previous filing: 16 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OBCI	Common Stock ($0.01 par value)	Disposed to Issuer	$2,345,649	-179,331	-100%	$13.08	0	09 Aug 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jeffrey Barocas is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Disposed of pursuant to the terms of the agreement and plan of merger, dated June 21, 2022, by and among Ocean Bio-Chem, Inc., a Florida corporation (the "Issuer"), OBCMS Inc., a Florida corporation ("Merger Sub") and direct, wholly-owned subsidiary of OneWater Marine Inc., a Delaware corporation ("Parent"), Merger Sub merged with and into the Issuer with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Parent.

Content

Disposed of pursuant to the terms of the agreement and plan of merger, dated June 21, 2022, by and among Ocean Bio-Chem, Inc., a Florida corporation (the "Issuer"), OBCMS Inc., a Florida corporation ("Merger Sub") and direct, wholly-owned subsidiary of OneWater Marine Inc., a Delaware corporation ("Parent"), Merger Sub merged with and into the Issuer with the Issuer being the surviving corporation and becoming a wholly-owned subsidiary of Parent.